Cardiac Risk Indicators
Cardiac Risk Indicators - Related Videos
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
0 Views •
Cited by 3 •
2011
Techniques for measurement of electrical activity of the heart by electrocardiogram (ECG), and analysis of cardiac risk factors and susceptibility to arrhythmias following status epilepticus (SE) in the rat are described.
02:39
Indicators
0 Views •
2020
Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are called...
08:17
Water Quality Analysis via Indicator Organisms
0 Views •
2023
Source: Laboratories of Dr. Ian Pepper and Dr. Charles Gerba -The University of Arizona Demonstrating Author: Luisa Ikner Water quality analysis monitors anthropogenic influences such as pollutants, nutrients, pathogens, and any other constituent that can impact the water’s integrity as a resource. Fecal contamination contributes microbial pathogens that threaten plant, animal, and human health with disease or illness. Increasing water demands and strict quality standards require that water...
07:39
Cardiac Exam I: Inspection and Palpation
0 Views •
2023
Source: Suneel Dhand, MD, Attending Physician, Internal Medicine, Beth Israel Deaconess Medical Center The cardiac assessment is one of the core examinations performed by almost every physician whenever encountering a patient. Disorders of the cardiac system are among the most common reasons for hospital admission, with conditions ranging from myocardial infarction to congestive heart failure. Learning a complete and thorough cardiac examination is therefore crucial for any practicing physician.
05:15
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
0 Views •
Cited by 2 •
2022
The present protocol describes methods for transgene expression in rat and mouse hearts by direct intramyocardial injection of the virus under echocardiography guidance. Methods for the assessment of the susceptibility of hearts to ventricular arrhythmias by the programmed electrical stimulation of isolated, Langendorff-perfused hearts are also explained here.
FAQs
Their value comes from combining findings that reflect different aspects of cardiovascular stress or vessel damage. Blood pressure, atherogenic cholesterol, glucose regulation, inflammation, and cardiac function may each contribute information, while age, smoking history, and family history add patient context. Considering the full pattern helps clinicians estimate risk more meaningfully than relying on one measurement alone.
These findings point to processes that can damage blood vessels or increase strain on the cardiovascular system. Elevated blood pressure reflects pressure-related stress, atherogenic cholesterol signals an unfavorable lipid pattern, and impaired glucose regulation indicates metabolic dysfunction. When several appear together, clinicians may view the overall profile as more concerning and consider earlier preventive attention.
They provide personal context that laboratory findings and clinical measurements cannot capture on their own. Age helps characterize a patient's background risk, smoking history identifies an important exposure, and family history indicates inherited or shared familial susceptibility. Including these characteristics allows clinicians to interpret biomarkers and cardiac findings within the patient's broader risk profile.
During screening, clinicians gather measurable findings and patient characteristics to identify people who may need closer evaluation. Risk stratification then separates patients according to the apparent likelihood of cardiovascular disease or a future cardiac event. This information can guide decisions about lifestyle counseling, additional diagnostic testing, and whether earlier intervention deserves consideration.
Assessment may include clinical findings such as blood pressure, biomarkers such as atherogenic cholesterol and measures of glucose regulation, indicators of inflammation, and evidence related to cardiac function. Clinicians also consider age, smoking history, and family history. Together, these inputs provide both biological and personal information for evaluating cardiovascular risk and planning next steps.
The combined profile helps clinicians tailor prevention to the individual's apparent level and pattern of risk. Results may support lifestyle counseling, prompt diagnostic testing, or identify a need for earlier intervention. Because the indicators reflect different processes, their interpretation can help focus preventive attention on patients whose findings or characteristics suggest greater cardiovascular concern.